With personalized support, we can help you get started on LYNAVOY (linerixibat) tablets

Once you and your healthcare provider decide that treatment with LYNAVOY is right for you,
your Care Manager Team will be here to help.

  • Enroll in Interconnect

    Your doctor will fill out an enrollment packet that includes HIPAA, patient consent, and program services opt-in forms. To begin the LYNAVOY fulfillment process, you must sign these forms.

  • Sign your forms

    You can sign the enrollment forms in person at your doctor’s office.

Frequently asked questions

How do I enroll in Interconnect?
If your healthcare provider determines that treatment support with Interconnect makes sense for you, they will complete an enrollment packet that includes your prescription. Once you have provided your signature, you will be enrolled in Interconnect. If your packet is completed but still needs your signature, please call Interconnect at 1-844-622-4278.
When will I know who my Care Manager will be?
The entire Care Manager Team is here to support you and has all the information needed to assist you effectively.
I would like to speak with a Care Manager who speaks Spanish. Is that possible?
Interconnect has a language translation line for live support in over 100 languages.
How often will I hear from my Care Manager?
Once you are enrolled, a Care Manager will call you to discuss the details of your prescription and initial questions you may have. They may check in with you thereafter if necessary. You can also feel free to call your Care Manager Team between the hours of 8 AM-8 PM ET, Monday-Friday, excluding holidays.
What is a specialty pharmacy?
A specialty pharmacy is different from your local pharmacy. A specialty pharmacy coordinates the delivery of specialized medicines such as LYNAVOY (linerixibat) tablets. Your medicine can be shipped to your home or place of employment, if requested.
Which specialty pharmacies provide support for LYNAVOY (linerixibat)?
PANTHERx Rare is the exclusive specialty pharmacy provider for LYNAVOY.

LYNAVOY treatment is not available through other specialty pharmacies.
When should I order refills of my LYNAVOY treatment?
Getting your refills on time matters. It can help you stay on track with your treatment, which is important for managing your condition. Ordering refills about a week before you run out of your treatment can help you have your new supply when you need it. Your Care Manager Team can help connect you to your specialty pharmacy to schedule deliveries and resolve any issues with your refills.
How will my Care Manager work with my healthcare provider’s office?
Your healthcare provider’s office will have access to your Care Manager Team, who will keep in touch with both of you throughout the process. Your Care Manager Team will communicate with office staff about prior authorizations and coverage for your LYNAVOY specialty pharmacy deliveries, refills, and more.
Can I call Interconnect if I have questions about my LYNAVOY treatment?
For questions about LYNAVOY, we always recommend speaking with your healthcare provider. To report negative side effects of treatment, please contact Alfasigma Pharmaceuticals, Inc., at 1-844-782-4278 or you may report to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For questions regarding accessing your product, or if you are unsure where to go for your question, please contact Alfasigma to help navigate to the right location.
Is everything I discuss with my Care Manager confidential?
Confidentiality is very important to Alfasigma. We will only share your information as described in the HIPAA Authorization you sign as part of the enrollment process for Interconnect. When you work with your healthcare provider to complete your Interconnect Enrollment form, there is a section called HIPAA Authorization on page 2 that explains the types of information that may be shared between your healthcare provider(s), health insurance provider(s), and Alfasigma. You’ll need to review this section and provide your signature if you agree.

You are now leaving Interconnect

Any information you provide after you leave this site and enter another site will be subject to the other website’s privacy policy and terms and conditions. Interconnect is not responsible for the use, security, or disclosure of any information you may provide to another site.

The information on this site is intended for healthcare professionals in the United States, its territories, and Puerto Rico, and is not intended for the general public.

Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., has voluntarily withdrawn OCALIVA® (obeticholic acid) from the market for the treatment of primary biliary cholangitis (PBC), effective November 14.

Patients should talk to their healthcare professionals and may also contact Intercept's patient support services (Interconnect at 1-844-622-4278) through December 31, 2025.

Interconnect's website is being temporarily maintained and is no longer fully functional for enrollment purposes due to the withdrawal of OCALIVA.

Healthcare professionals can contact Medical Information at medinfo@interceptpharma.com or 1-844-782-4278. Additionally, patients or healthcare professionals may request Full Prescribing Information or the OCALIVA Medication Guide by contacting medinfo@interceptpharma.com.

For all other inquiries please contact: info@interceptpharma.com